Holen Sie sich die Stockscreener-App
1.30
0.78%
0.01
Schlusskurs vom Vortag:
$1.29
Offen:
$1.3
24-Stunden-Volumen:
132.55K
Relative Volume:
0.07
Marktkapitalisierung:
$13.82M
Einnahmen:
$23.28M
Nettoeinkommen (Verlust:
$-23.75M
KGV:
-0.4262
EPS:
-3.05
Netto-Cashflow:
$-25.22M
1W Leistung:
-5.11%
1M Leistung:
-6.47%
6M Leistung:
-27.78%
1J Leistung:
-74.31%
1-Tages-Spanne:
$1.27
$1.32
1-Wochen-Bereich:
$1.27
$1.48
52-Wochen-Spanne:
$1.22
$5.25
Lifeward Ltd Stock (LFWD) Company Profile
Firmenname
Lifeward Ltd
Sektor
Branche
Telefon
15082511154
Adresse
200 DONALD LYNCH BLVD., MARLBOROUGH
Vergleichen Sie LFWD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LFWD
Lifeward Ltd
|
1.30 | 14.56M | 23.28M | -23.75M | -25.22M | -3.05 |
|
ABT
Abbott Laboratories
|
134.80 | 231.82B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
106.04 | 152.18B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
394.21 | 145.57B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
86.44 | 107.07B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
78.00 | 43.22B | 5.54B | 4.18B | 623.10M | 7.00 |
Lifeward Ltd Stock (LFWD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-10 | Eingeleitet | Laidlaw | Buy |
| 2017-04-03 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2016-12-16 | Eingeleitet | Oppenheimer | Outperform |
| 2016-07-15 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-05-22 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2015-05-08 | Bestätigt | Barclays | Equal Weight |
| 2014-10-07 | Eingeleitet | Barclays | Equal Weight |
Alle ansehen
Lifeward Ltd Aktie (LFWD) Neueste Nachrichten
Lifeward reaffirms $28M–$30M 2025 revenue guidance as pipeline expands 70% and cost controls tighten - MSN
Lifeward files $100M mixed securities shelf - MSN
Lifeward: Q1 Earnings Snapshot - CT Insider
Lifeward Ltd (LFWD) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... - Yahoo Finance
Lifeward Inc. Earnings Call: Optimism Amid Challenges - TipRanks
LFWD Misses Q1 Revenue Estimates, Expects Improvement in Medicare Claims Process | LFWD Stock News - GuruFocus
Lifeward earnings missed by $0.18, revenue fell short of estimates - Investing.com Australia
Lifeward (LFWD) Announces $100 Million Mixed Securities Shelf Of - GuruFocus
Lifeward Ltd Q1 2025 Earnings: EPS Misses at -$0.46, Revenue Fal - GuruFocus
Transcript : Lifeward Ltd., Q1 2025 Earnings Call, May 15, 2025 - marketscreener.com
Lifeward Ltd. Provides Revenue Guidance for the Year 2025 - marketscreener.com
Lifeward (LFWD) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
Lifeward Ltd. SEC 10-Q Report - TradingView
Form 10-Q Lifeward Ltd. For: Mar 31 - StreetInsider
Lifeward (LFWD) Maintains Revenue Outlook for 2025 | LFWD Stock News - GuruFocus
ReWalk Robotics Q1 2025 Earnings Report - MarketBeat
Lifeward Ltd. Reports First Quarter 2025 Financial Results | LFW - GuruFocus
Lifeward Ltd. Reports First Quarter 2025 Financial Results - GlobeNewswire
Lifeward (LFWD) Advances Exoskeleton Technology with AI Integration | LFWD Stock News - GuruFocus
Lifeward Completes Research Program with Israeli - GlobeNewswire
Lifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and Exoskeletons - marketscreener.com
Lifeward to Report First Quarter 2025 Financial Results on May 1 - GuruFocus
Lifeward to Report First Quarter 2025 Financial Results on May 15, 2025 | LFWD Stock News - GuruFocus
Lifeward Ltd. to Release First Quarter 2025 Financial Results on May 15, 2025 - Nasdaq
Lifeward to Report First Quarter 2025 Financial Results on May 15, 2025 - GlobeNewswire
Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results - ADVFN
Lifeward (LFWD) Secures Insurance Approval for ReWalk 7 Exoskele - GuruFocus
First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton - GlobeNewswire
Major Insurance Breakthrough: ReWalk 7 Exoskeleton Gets Historic First Commercial Coverage - Stock Titan
Lifeward Ltd. Reports Third Quarter 2024 Financial Results - ADVFN
Israeli Soldier Becomes First War Casualty to Use ReWalk Exoskeleton (LFWD) | LFWD Stock News - GuruFocus
Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Per - GuruFocus
Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Personal Exoskeleton - The Manila Times
Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Personal Exoskeleton | LFWD Stock News - GuruFocus
Revolutionary ReWalk Exoskeleton Helps Paralyzed Israeli Soldier Walk: Military Healthcare Breakthrough - Stock Titan
Lifeward launches sales of ReWalk 7 personal exoskeleton in U.S. - MSN
LFWD Stock Falls Despite Launch of Next-Generation Mobility ReWalk 7 - MSN
Lifeward launches ReWalk 7 exoskeleton for spinal injury patients By Investing.com - Investing.com South Africa
Lifeward (LFWD) Launches ReWalk 7 Exoskeleton in the U.S., Shares Rise - GuruFocus
Lifeward (LFWD) Launches Next-Gen ReWalk 7 Personal Exoskeleton Nationwide | LFWD Stock News - GuruFocus
Lifeward launches ReWalk 7 exoskeleton for spinal injury patients - Investing.com Australia
Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market | LFWD Stock News - GuruFocus
Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market - The Manila Times
Lifeward Launches Sales Of The ReWalk 7 Personal Exoskeleton In U.S. Market - Barchart.com
Lifeward Ltd. reports preliminary Q1 financial results - Investing.com Australia
Lifeward Ltd. reports preliminary Q1 financial results By Investing.com - Investing.com Canada
Finanzdaten der Lifeward Ltd-Aktie (LFWD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.85%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):